Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Dobbelstein

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Antiviral Research|October 5, 2025
Inhibitors of pyrimidine synthesis synergize with N4-hydroxycytidine to diminish influenza virus replicationLeon Schrell, David Scheibner, Antje Dickmanns, et al.
The Journal of Biological Chemistry|January 15, 2002
YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoterPer S Holm, Stephan Bergmann, Karsten Jurchott, et al.
Molecular Cell|July 7, 2015
MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMPXin Zhang, Ramona Schulz, Shelley Edmunds, et al.
Antiviral Research|July 31, 2025
The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replicationDoha Al Krad, Kim M Stegmann, Antje Dickmanns, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 13, 2013
Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7gJunius Salendo, Melanie Spitzner, Frank Kramer, et al.
Cell Death & Disease|January 6, 2025
Alternative splicing in the DBD linker region of p63 modulates binding to DNA and iASPP in vitroRebecca Lotz, Christian Osterburg, Apirat Chaikuad, et al.
Iscience|September 21, 2023
N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobodyArne Zibat, Xiaoxiao Zhang, Antje Dickmanns, et al.
Oncogene|May 20, 2020
Mdm4 supports DNA replication in a p53-independent fashionKai Wohlberedt, Ina Klusmann, Polina K Derevyanko, et al.
EMBO Reports|October 7, 2018
Loss of <i>CHD1</i> causes DNA repair defects and enhances prostate cancer therapeutic responsivenessVijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
EMBO Reports|September 7, 2016
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsivenessVijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Antiviral Research|October 5, 2025
Inhibitors of pyrimidine synthesis synergize with N4-hydroxycytidine to diminish influenza virus replicationLeon Schrell, David Scheibner, Antje Dickmanns, et al.
The Journal of Biological Chemistry|January 15, 2002
YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoterPer S Holm, Stephan Bergmann, Karsten Jurchott, et al.
Molecular Cell|July 7, 2015
MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMPXin Zhang, Ramona Schulz, Shelley Edmunds, et al.
Antiviral Research|July 31, 2025
The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replicationDoha Al Krad, Kim M Stegmann, Antje Dickmanns, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 13, 2013
Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7gJunius Salendo, Melanie Spitzner, Frank Kramer, et al.
Cell Death & Disease|January 6, 2025
Alternative splicing in the DBD linker region of p63 modulates binding to DNA and iASPP in vitroRebecca Lotz, Christian Osterburg, Apirat Chaikuad, et al.
Iscience|September 21, 2023
N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobodyArne Zibat, Xiaoxiao Zhang, Antje Dickmanns, et al.
Oncogene|May 20, 2020
Mdm4 supports DNA replication in a p53-independent fashionKai Wohlberedt, Ina Klusmann, Polina K Derevyanko, et al.
EMBO Reports|October 7, 2018
Loss of <i>CHD1</i> causes DNA repair defects and enhances prostate cancer therapeutic responsivenessVijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
EMBO Reports|September 7, 2016
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsivenessVijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
Pageof 11